All Relations between Spinal Cord Injuries and Tizanidine
| Publication | Sentence | Publish Date | Extraction Date | Species |
|---|---|---|---|---|
| Huda Salem AlSalem, Sara Naif Alharbi, Mona Saad Binkadem, Soha Talal Al-Goul, Ahmed A Abu-Hassan, Mohamed Oraby, Mohamed A Abdel-Latee. A nano-level assay of tizanidine using the fluorogenic character of benzofurazan derivative: Application to plasma, tablets, and content homogeneity evaluation. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy. vol 320. 2024-06-08. PMID:38850823. | people frequently administer tizanidine (tiz) to treat spasticity resulting from diseases like multiple sclerosis or spinal cord injuries. | 2024-06-08 | 2024-06-11 | Not clear |
| C J Mathias, J Luckitt, P Desai, H Baker, W el Masri, H L Franke. Pharmacodynamics and pharmacokinetics of the oral antispastic agent tizanidine in patients with spinal cord injury. Journal of rehabilitation research and development. vol 26. issue 4. 1990-02-01. PMID:2600869. | we conclude that oral tizanidine has antispastic effects in patients with spinal cord injuries without affecting the power of non-involved muscle groups. | 1990-02-01 | 2023-08-11 | Not clear |
| C J Mathias, J Luckitt, P Desai, H Baker, W el Masri, H L Franke. Pharmacodynamics and pharmacokinetics of the oral antispastic agent tizanidine in patients with spinal cord injury. Journal of rehabilitation research and development. vol 26. issue 4. 1990-02-01. PMID:2600869. | the efficiency and duration of action of a single oral dose (8 mg) of tizanidine in patients with spinal cord injuries were determined by studying its antispastic, cardiovascular and sedative effects along with its pharmacokinetic profile in five tetraplegic and five paraplegic patients. | 1990-02-01 | 2023-08-11 | Not clear |